Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04550312
Other study ID # XYFY2020-KL142-01
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date September 2020
Est. completion date October 2020

Study information

Verified date September 2020
Source The First Affiliated Hospital with Nanjing Medical University
Contact ming chu, PHD
Phone 86-2568136965
Email chuming@njmu.edu.cn
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The increase of all-cause mortality in the areas with high COVID-19 transmission rate due to COVID-19 deaths and the collateral damage to other healthcare problems is well known. However, the COVID-19 mortality is very low in the regions with low transmission rate and sufficient medical resources. In such regions, strict prevention measures were taken and these would alter the people's lifestyle and hygienic habits and further impact on non-COVID-19 deaths. Yet, there has no thorough investigation in this aspect.


Description:

Background The increase of all-cause mortality in the areas with high COVID-19 transmission rate due to COVID-19 deaths and the collateral damage to other healthcare problems is well known. However, the COVID-19 mortality is very low in the regions with low transmission rate and sufficient medical resources. In such regions, strict prevention measures were taken and these would alter the people's lifestyle and hygienic habits and further impact on non-COVID-19 deaths. Yet, there has no thorough investigation in this aspect.

Methods The number of registered deaths among 8.8 million permanent residents with specific causes from January 2018 to June 2020 were sourced from the Xuzhou Center for Disease Control and Prevention, Jiangsu Province, China. Death rates were calculated and compared by weeks, months, and years with a focus on the period of COVID-19 pandemic from Jan 24 to March 27, 2020. Numeric values of all-cause death and the death rates of non-COVID diseases were compared in time series at different time scales.


Recruitment information / eligibility

Status Recruiting
Enrollment 80000
Est. completion date October 2020
Est. primary completion date October 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- All cases of death reported to the Xuzhou CDC during the study period

Exclusion Criteria:

- no

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
China Xuzhou Medical University affiliated Hospital Xuzhou Jiangsu

Sponsors (1)

Lead Sponsor Collaborator
The First Affiliated Hospital with Nanjing Medical University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Numeric values of all-cause death and the death rates of non-COVID diseases from January 2018 to June 2020